3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
2
Sponsor
Cancer Type
Head & Neck
609
Thoracic
120
Gastrointestinal
113
Breast
81
Gynecologic
77
Genitourinary
70
Dermatologic
55
CNS
30
Sarcoma
28
Lymphoid
13
Endocrine
10
Other solid neoplasm
9
Other hematologic neoplasm
7
Other neoplasm
3
NET
3
Plasma cell
2
Other
2
Myeloid
1
Classical hematology
1
Conditions
Multiple Myeloma
937
Lymphoma
113
Recurrence
93
Neoplasms, Plasma Cell
92
Lymphoma, Non-Hodgkin
68
Immunoglobulin Light-chain Amyloidosis
60
Hematologic Neoplasms
60
Neoplasms
54
Smoldering Multiple Myeloma
52
Leukemia, Myeloid, Acute
51
Leukemia
51
Myelodysplastic Syndromes
47
Leukemia, Lymphocytic, Chronic, B-Cell
45
Precursor Cell Lymphoblastic Leukemia-Lymphoma
38
Hodgkin Disease
38
Leukemia, Plasma Cell
27
Myeloproliferative Disorders
24
Breast Neoplasms
24
Monoclonal Gammopathy of Undetermined Significance
23
Lymphoma, Large B-Cell, Diffuse
23
Lymphoma, Mantle-Cell
22
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
22
Amyloidosis
22
Primary Myelofibrosis
21
Lymphoma, Follicular
21
Waldenstrom Macroglobulinemia
20
Ovarian Neoplasms
20
Lymphoma, B-Cell, Marginal Zone
17
Lymphoma, B-Cell
17
Colorectal Neoplasms
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Plasma cell
×
1 year
×
Clear all
NCT05366881
2026-01-20
CAMPERR
Adela, Inc
Recruiting
7,000 enrolled
NCT03702309
2025-11-26
LIBERATE
University Health Network, Toronto
Recruiting
2,500 enrolled